ST Bloodstock Ltd 14938863 true 2024-07-01 2025-06-30 2025-06-30 The principal activity of the company is dormant. Digita Accounts Production Advanced 6.30.9574.0 true Mr Sebastian Charles Thompson true 14938863 2024-07-01 2025-06-30 14938863 2025-06-30 14938863 core:ShareCapital 2025-06-30 14938863 bus:FRS102 2024-07-01 2025-06-30 14938863 bus:AuditExempt-NoAccountantsReport 2024-07-01 2025-06-30 14938863 bus:FullAccounts 2024-07-01 2025-06-30 14938863 bus:RegisteredOffice 2024-07-01 2025-06-30 14938863 bus:Director1 2024-07-01 2025-06-30 14938863 bus:EntityHasNeverTraded 2024-07-01 2025-06-30 14938863 bus:PrivateLimitedCompanyLtd 2024-07-01 2025-06-30 14938863 countries:AllCountries 2024-07-01 2025-06-30 14938863 2024-06-30 14938863 core:ShareCapital 2024-06-30 iso4217:GBP

Registration number: 14938863

ST Bloodstock Ltd
Annual Report and Unaudited Financial Statements
for the Year Ended 30 June 2025

ST Bloodstock Ltd

Profit and Loss Account for the Year Ended 30 June 2025

The company has not traded during the year. During this year, the company received no income and incurred no expenditure and therefore made neither profit nor loss.

ST Bloodstock Ltd

(Registration number: 14938863)
Balance Sheet as at 30 June 2025

| Note | 2025 £ | 2024 £
Current assets |  |  |
Cash at bank and in hand |  | 100 | 100
Capital and reserves |  |  |
Called up share capital | 4 | 100 | 100
Shareholders' funds |  | 100 | 100

For the financial year ending 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

For the financial year ending 30 June 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the director on 24 March 2026

......................................... Mr Sebastian Charles Thompson Director

ST Bloodstock Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2025

1 | General information

The company is a private company limited by share capital, incorporated in England & Wales..

The address of its registered office is:
Smeaton Manor Stables
Great Smeaton
Northallerton
North Yorkshire
DL6 2NF

These financial statements were authorised for issue by the director on 24 March 2026.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3 | Cash and cash equivalents

| 2025 £ | 2024 £
Cash at bank | 100 | 100

4 | Share capital

Allotted, called up and fully paid shares

ST Bloodstock Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2025

| 2025 | 2024
| No. | £ | No. | £
Ordinary of £1 each | 100 | 100 | 100 | 100